About JUVIC
JUVIC is a company based in Seoul (South Korea) founded in 2015 by Hyungil Jung. JUVIC operates in a competitive market with competitors including PolyPid, PanTher Therapeutics, Santen Pharmaceuticals, Zyl Therapeutics and Hallux, among others.
- Headquarter Seoul, South Korea
- Founders Hyungil Jung
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Zoobic Co., Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of JUVIC
Detailed funding history for JUVIC
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by JUVIC
Investment portfolio details for JUVIC
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - JUVIC
Detailed financials for JUVIC
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Juvic Comparisons
Peer comparison for JUVIC
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of JUVIC
JUVIC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PolyPid, PanTher Therapeutics, Santen Pharmaceuticals, Zyl Therapeutics and Hallux, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology platform enabling controlled and prolonged release of any Active Pharmaceutical Ingredient (API)
|
|
| Locked | Locked | Locked |
Drug delivery systems for inoperable solid tumors are developed.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for ophthalmology and rheumatology diseases are manufactured.
|
|
| Locked | Locked | Locked |
Hydrogel-derived nanoparticles for topical drug delivery are developed.
|
|
| Locked | Locked | Locked |
Subungual drug delivery technology for onychomycosis treatment is provided.
|
|
| Locked | Locked | Locked |
Patented drug delivery technology is developed for bioactive molecules.
|
Detailed competitors of JUVIC
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Juvic
Complete news archive for JUVIC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JUVIC
JUVIC was founded in 2015.
JUVIC is headquartered in Seoul, South Korea.
Ben Kim is the current CEO of JUVIC.
JUVIC was founded in 2015 in Seoul, South Korea, and operates in the biotechnology sector. Polymer-based drug delivery systems are developed, including biodegradable microneedles that enable loading of lipid-soluble drugs. Low-temperature pillar transfer methodology is utilized, along with graft technology for transdermal drug administration. Operations focus on innovative delivery solutions for pharmaceutical applications.
JUVIC's top competitors include PanTher Therapeutics, PolyPid and Lexaria Bioscience.